Medullary thyroid carcinoma (MTC) and RET proto-oncogene: Mutation spectrum in the familial cases and a meta-analysis of studies on the sporadic form

被引:57
作者
Figlioli, Gisella [1 ]
Landi, Stefano [1 ]
Romei, Cristina [2 ]
Elisei, Rossella [2 ]
Gemignani, Federica [1 ]
机构
[1] Univ Pisa, Dept Biol, I-56124 Pisa, Italy
[2] Univ Pisa, Dept Endocrinol, I-56124 Pisa, Italy
关键词
Medullary thyroid carcinoma; RET gene mutations; RET gene polymorphisms; Meta-analysis; ENDOCRINE NEOPLASIA TYPE-2; CODON; 918; MUTATION; GERMLINE-SEQUENCE VARIANTS; TYROSINE KINASE ACTIVATION; TERM-FOLLOW-UP; PROGNOSTIC-FACTORS; MEN; 2A; MULTIVARIATE-ANALYSIS; DISEASE PHENOTYPE; CLINICOPATHOLOGICAL FEATURES;
D O I
10.1016/j.mrrev.2012.09.002
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Medullary thyroid carcinoma (MTC) is an uncommon malignant tumor arising from the calcitonin-producing parafollicular cells (C cells) of thyroid. It accounts for 5-10% of all thyroid cancers, and it mostly occurs as a sporadic entity (sMTC), but a familial pattern (fMTC) is also possible. RET protooncogene germline mutations are crucial for the onset and the progression of fMTC, and the occurrence of single nucleotide polymorphisms could predispose to the sporadic form. In order to clarify the role of this gene in MTC, we carefully reviewed the PubMed database using appropriate terms. First, we summarized current knowledge of the germline RET mutations, mutation spectrum, and prevalence. We then performed a meta-analysis on the available case-control association studies for sMTC. Finally, we carried out in silico predictions of the best associated variants in the attempt to better define their role in the disease. To date, a total of 39 different RET germline mutations have been identified in fMTC families. The most affected codons are 609, 611, 618, 620 (exon 10) and 634 (exon 11), encoding for the extracellular cysteine-rich domain, and codons 768 (exon 13) and 804 (exon 14) of the intracellular tyrosine kinase domain. Six polymorphisms with at least three studies were included in the meta-analysis (A45A [rs1800858], G691S [rs1799939], L769L [rs1800861 I, S836S [rs1800862], S904S [rs1800863], and IVS1-126G>T [rs2565206]). The meta-analysis demonstrated a modest association of sMTC susceptibility with S836S and a strong association with the IVS1-126G>T polymorphism. Besides RET polymorphisms, we also investigated the role of a few other low-penetrance alleles of genes involved in the RET pathway or in xenobiotic metabolism, but none of these were confirmed. Thus, despite the well-known molecular basis of fMTC, the genetic variants of the sporadic form are still poorly understood, and functional analyses are needed to better understand the consequence of such RET variants and to improve our knowledge on the disease. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:36 / 44
页数:9
相关论文
共 50 条
  • [21] Clinical significance of RET and RAS mutations in sporadic medullary thyroid carcinoma: a meta-analysis
    Huy Gia Vuong
    Odate, Toru
    Ngo, Hanh T. T.
    Thong Quang Pham
    Tran, Thao T. K.
    Mochizuki, Kunio
    Nakazawa, Tadao
    Katoh, Ryohei
    Kondo, Tetsuo
    ENDOCRINE-RELATED CANCER, 2018, 25 (06) : 633 - 641
  • [22] Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma
    Qi, X-P.
    Ying, R-B.
    Ma, J-M.
    Liu, W-T.
    Du, Z-F.
    Fei, J.
    Yang, C-P.
    Song, Q-Z.
    Jin, H-Y.
    Chen, Z-G.
    Han, J-S.
    Wang, J-Q.
    Chen, X-L.
    Zhao, Y.
    Lu, J-J.
    Zhang, X-N.
    FAMILIAL CANCER, 2012, 11 (01) : 131 - 136
  • [23] Germline polymorphisms on RET proto-oncogene involved in medullary thyroid carcinoma in a Druze family
    Azzam, Naiel
    Bar-Shalom, Rinat
    Saab, Anwar
    Fares, Fuad
    EUROPEAN JOURNAL OF CANCER, 2017, 82 : 149 - 152
  • [24] Selective repression of RET proto-oncogene in medullary thyroid carcinoma by a natural alkaloid berberine
    Vishnu Muthuraj Kumarasamy
    Yoon-Joo Shin
    John White
    Daekyu Sun
    BMC Cancer, 15
  • [25] Skewed mutational spectrum of RET proto-oncogene Exon10 in Iranian patients with medullary thyroid carcinoma
    Yeganeh, Marjan Zarif
    Sheikholeslami, Sara
    Behbahani, Golnoush Dehbashi
    Farashi, Samaneh
    Hedayati, Mehdi
    TUMOR BIOLOGY, 2015, 36 (07) : 5225 - 5231
  • [26] Molecular Analysis of the RET Proto-Oncogene Key Exons in Patients with Medullary Thyroid Carcinoma: A Comprehensive Study of the Iranian Population
    Alvandi, Ehsan
    Akrami, Seyed Mohammad
    Chiani, Mohsen
    Hedayati, Mehdi
    Nayer, Babak Noori
    Tehrani, Mohammad Reza Mohajeri
    Nakhjavani, Manouchehr
    Pedram, Mehrdad
    THYROID, 2011, 21 (04) : 373 - 382
  • [27] Detection of RET proto-oncogene Cys634Arg mutation, the cause of Medullary Thyroid Carcinoma, in an Iranian child
    Alvandi, Ehsan
    Pedram, Mehrdad
    Soroush, Ahmad-Reza
    Naier, Babak Noori
    Akrami, Seyed Mohammad
    IRANIAN JOURNAL OF PEDIATRICS, 2007, 17 : 301 - 305
  • [28] Cys611Ser mutation in RET proto-oncogene in a kindred with medullary thyroid carcinoma and Hirschsprung's disease
    Nishikawa, M
    Murakumo, Y
    Imai, T
    Kawai, K
    Nagaya, M
    Funahashi, H
    Nakao, A
    Takahashi, M
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2003, 11 (05) : 364 - 368
  • [29] RET proto-oncogene mutations in multiple endocrine neoplasia type 2 and medullary thyroid carcinoma
    Marsh, DJ
    Mulligan, LM
    Eng, C
    HORMONE RESEARCH, 1997, 47 (4-6) : 168 - 178
  • [30] Characterization of Wild-Type and Mutated RET Proto-Oncogene Associated with Familial Medullary Thyroid Cancer
    Masbi, Mohammad Hosein
    Mohammadiasl, Javad
    Galehdari, Hamid
    Ahmadzadeh, Ahmad
    Tabatabaiefar, Mohammad Amin
    Golchin, Neda
    Haghpanah, Vahid
    Rahim, Fakher
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (05) : 2027 - 2033